Gottlieb, S. 2004. Vaccine Makers Get a Shot in the Arm. Available: [accessed November 23, 2009].

Gross, C.P., G.F. Anderson, and N.R. Powe. 1999. The relation between funding by the National Institutes of Health and the burden of disease. NELM 340(24):1881-1887.

HHS (Department of Health and Human Services). 2008 (November). Draft Strategic National Vaccine Plan. Available: [accessed December 2008].

HHS. 2009. BARDA Influenza & Emerging Disease Program. Available: [accessed November 23, 2009].

HHS, NIH (National Institutes of Health), and NIAID (National Institute of Allergy and Infectious Diseases). 2002. The Jordan Report, 20th Anniversary: Accelerated Development of Vaccines. Washington, DC: HHS.

HHS, NIH, and NIAID. 2007. The Jordan Report, Accelerated Development of Vaccines. Washington, DC: HHS.

Hoyt, K. 2006. Vaccine innovation: Lessons from World War II. J Public Health Pol 27(1): 38-60.

Hynes, N.A. 2007. Project bioshield a tool for developing, using, and stockpiling needed public health emergency medical countermeasures. The Jordan Report, Accelerated Development of Vaccine 2007 27-36.

IOM (Institute of Medicine). 1985a. New Vaccine Development: Establishing Priorities: Volume 2, Diseases of Importance in Developing Countries. Washington, DC: National Academy Press.

IOM. 1985b. New Vaccine Development: Establishing Priorities: Volume 1, Diseases of Importance in the United States. Washington, DC: National Academy Press.

IOM. 2000. Vaccines for the 21st Century. Washington, DC: National Academy Press.

IOM. 2004. Financing Vaccines in the 21st Century: Assuring Access and Availability. Washington, DC: The National Academies Press.

IOM. 2008 (December 1). Transcript, Second National Stakeholder Meeting of the IOM Committee on Review of Priorities in the National Vaccine Plan. Irvine, CA: IOM.

Kataoka, M., A. Yamamoto, M. Ochiai, A. Harashima, N. Nagata, H. Hasegaw, T. Kurata, and Y. Horiuchi. 2009. Comparison of acellular pertussis-based combination vaccines by Japanese control tests for toxicities and laboratory models for local reaction. Vaccine 27:1881-1888.

Klein, J.O., and M.G. Myers. 2006. Strengthening the supply of routinely administered vaccines in the United States: Problems and proposed solutions. Clin Infect Dis 42(Suppl 3):S97-S103.

Landry, S., and C. Heilman. 2005. Future directions in vaccines: The payoffs of basic research. Health Aff 24(3):758-769.

Miller, H.I., and D.R. Henderson. 2007. Governmental influences on drug development: Striking a better balance. Nat Rev Drug Discov 6(7):532-539.

Milstien, J.B. 2004. Regulation of vaccines: Strengthening the science base. J Public Health Pol 25(2):173-189.

Nature Reviews Drug Discovery. 2008. The drought continues. Nature 7:105.

Neumann, P.J., A.B. Rosen, D. Greenberg, N.V. Olchanski, R. Pande, R.H. Chapman, P.W. Stone, S. Ondategui-Parra, J. Nadai, J.E. Siegel, and M.C. Weinstein. 2005. Can we better prioritize resources for cost-utility research? Med Decis Making 25(4):429-436.

NIH (National Institutes of Health). 2009a. Research Project Grants: New (type 1) Awards and Percentage to Targeted Research. Available: [accessed October 2009].

NIH. 2009b. R01-Equivalent Grants: Awards as a Percentage of all Research Grants. Available: [accessed October 2009].

The National Academies of Sciences, Engineering, and Medicine
500 Fifth St. N.W. | Washington, D.C. 20001

Copyright © National Academy of Sciences. All rights reserved.
Terms of Use and Privacy Statement